No Data
No Data
Truist Financial Maintains Curis(CRIS.US) With Buy Rating
Truist Removes Price Target on Curis Due to Volatility, Low Share Price; Price Target Was $26, Buy Rating Kept
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Upgrade: Analysts Just Made A Meaningful Increase To Their Curis, Inc. (NASDAQ:CRIS) Forecasts
H.C. Wainwright Maintains Curis(CRIS.US) With Buy Rating, Maintains Target Price $16
Curis to Present at Upcoming Healthcare Conference in April